Cyclosporine Therapy and Refractory Pneumocystis carinii Pneumonia
- 1 September 1987
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 122 (9) , 1034-1035
- https://doi.org/10.1001/archsurg.1987.01400210072010
Abstract
• In surveillance of 75 patients receiving renal transplants in 1984 at our Institution, five cases ofPneumocystis cariniipneumonia were detected. All five cases occurred in a subgroup of 11 patients who had received cyclosporine. A retrospective epidemiologic survey of the infected patients revealed all five were heterosexual white men with onset ofPneumocystispneumonia two to six months after cadaveric transplantation. All received cyclosporine and corticosteroids, and four of five patients also received azathioprine; none was neutropenic or had evidence of concurrent cytomegalovirus infection. Only one of these patients responded to therapy with sulfamethoxazole and trimethoprim, one patient responded to pentamidine therapy, and the remaining three patients died. Cyclosporine use may be related to development ofPneumocystisinfections that are refractory to conventional antiprotozoal therapy, and transplantation programs should closely survey patients for such complications. (Arch Surg1987;122:1034-1035)This publication has 8 references indexed in Scilit:
- Pneumocystis carinii Pneumonia in Renal-Transplant Recipients Treated with Cyclosporine and SteroidsThe Journal of Infectious Diseases, 1984
- EARLY INFECTIONS IN KIDNEY, HEART, AND LIVER TRANSPLANT RECIPIENTS ON CYCLOSPORINETransplantation, 1983
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Neutropenia and Thrombocytopenia in Renal Allograft Recipients Treated with Trimethoprim-SulfamethoxazoleAnnals of Internal Medicine, 1980
- Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.The Journal of Immunology, 1980
- Adverse reactions to co-trimoxazole in hospitalized medical patientsThe Lancet Healthy Longevity, 1978
- Effect of Trimethoprim-Sulfamethoxazole on the Renal Excretion of Creatinine in ManJournal of Urology, 1975
- LATENT PNEUMOCYSTIS INFECTION OF RATS RELAPSE AND CHEMOTHERAPY1966